| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromuscular Blocking Agents | 7 | 2013 | 29 | 1.460 |
Why?
|
| Critical Care | 14 | 2013 | 370 | 1.420 |
Why?
|
| Catheterization, Swan-Ganz | 7 | 2007 | 25 | 1.330 |
Why?
|
| Intensive Care Units | 9 | 2013 | 373 | 1.100 |
Why?
|
| Monitoring, Physiologic | 15 | 2022 | 268 | 1.090 |
Why?
|
| Public Policy | 3 | 2014 | 52 | 1.040 |
Why?
|
| Marketing | 2 | 2014 | 23 | 0.990 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2012 | 462 | 0.970 |
Why?
|
| Organizational Policy | 2 | 2014 | 55 | 0.960 |
Why?
|
| Drug Industry | 2 | 2014 | 54 | 0.950 |
Why?
|
| Cardiopulmonary Bypass | 8 | 2007 | 148 | 0.950 |
Why?
|
| Anesthesiology | 6 | 2022 | 157 | 0.830 |
Why?
|
| Neuromuscular Blockade | 6 | 2015 | 26 | 0.770 |
Why?
|
| Critical Illness | 11 | 2013 | 294 | 0.770 |
Why?
|
| Oximetry | 5 | 2015 | 84 | 0.750 |
Why?
|
| Laryngeal Masks | 1 | 2020 | 12 | 0.740 |
Why?
|
| Airway Management | 1 | 2020 | 46 | 0.700 |
Why?
|
| Fentanyl | 5 | 2009 | 65 | 0.690 |
Why?
|
| Anesthesia Recovery Period | 11 | 2015 | 56 | 0.670 |
Why?
|
| Postoperative Complications | 12 | 2015 | 2207 | 0.670 |
Why?
|
| Anesthesia | 5 | 2022 | 164 | 0.660 |
Why?
|
| Catheterization, Peripheral | 3 | 2009 | 58 | 0.650 |
Why?
|
| Morphine | 3 | 2009 | 130 | 0.620 |
Why?
|
| Monitoring, Intraoperative | 9 | 2017 | 109 | 0.620 |
Why?
|
| Coronary Artery Bypass | 6 | 2007 | 228 | 0.620 |
Why?
|
| Physicians | 3 | 2014 | 673 | 0.610 |
Why?
|
| Hypotension | 1 | 2017 | 70 | 0.580 |
Why?
|
| Ventricular Function | 2 | 2007 | 53 | 0.570 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 4 | 2008 | 14 | 0.500 |
Why?
|
| Intraoperative Care | 3 | 2022 | 82 | 0.490 |
Why?
|
| Analgesics, Opioid | 4 | 2017 | 413 | 0.480 |
Why?
|
| Anesthetics, Intravenous | 4 | 2009 | 41 | 0.480 |
Why?
|
| Airway Obstruction | 4 | 2015 | 109 | 0.480 |
Why?
|
| Hemodynamics | 9 | 2014 | 710 | 0.470 |
Why?
|
| Humans | 79 | 2022 | 86643 | 0.440 |
Why?
|
| Pain, Postoperative | 6 | 2017 | 240 | 0.440 |
Why?
|
| Blood Gas Analysis | 6 | 2004 | 37 | 0.420 |
Why?
|
| Brain Ischemia | 2 | 2012 | 398 | 0.380 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2015 | 57 | 0.380 |
Why?
|
| Hypoxia | 7 | 2015 | 641 | 0.380 |
Why?
|
| Anesthesia, General | 5 | 2022 | 114 | 0.380 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2007 | 344 | 0.360 |
Why?
|
| Pulmonary Artery | 3 | 2009 | 306 | 0.360 |
Why?
|
| Catheter-Related Infections | 1 | 2009 | 23 | 0.350 |
Why?
|
| Patient-Centered Care | 4 | 2015 | 203 | 0.350 |
Why?
|
| Perioperative Care | 3 | 2015 | 161 | 0.350 |
Why?
|
| Bacitracin | 1 | 2008 | 3 | 0.330 |
Why?
|
| Bacteremia | 1 | 2009 | 99 | 0.330 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 45 | 0.320 |
Why?
|
| Anaphylaxis | 1 | 2008 | 33 | 0.320 |
Why?
|
| Elective Surgical Procedures | 3 | 2010 | 116 | 0.320 |
Why?
|
| Blood Transfusion | 2 | 2006 | 157 | 0.320 |
Why?
|
| Brain | 2 | 2015 | 2216 | 0.300 |
Why?
|
| Spinal Fractures | 1 | 2008 | 75 | 0.300 |
Why?
|
| Health Care Costs | 1 | 2009 | 238 | 0.300 |
Why?
|
| Intraoperative Complications | 2 | 2008 | 185 | 0.300 |
Why?
|
| Aged | 26 | 2017 | 18415 | 0.290 |
Why?
|
| Mediastinoscopy | 1 | 2006 | 5 | 0.290 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 154 | 0.280 |
Why?
|
| Muscle Weakness | 6 | 2015 | 61 | 0.280 |
Why?
|
| Analgesics | 2 | 2004 | 119 | 0.280 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2006 | 12 | 0.280 |
Why?
|
| Middle Aged | 30 | 2017 | 25028 | 0.280 |
Why?
|
| Hypnotics and Sedatives | 2 | 2004 | 125 | 0.280 |
Why?
|
| Female | 36 | 2017 | 44532 | 0.270 |
Why?
|
| Embolism, Air | 2 | 2006 | 23 | 0.270 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 112 | 0.270 |
Why?
|
| Prospective Studies | 10 | 2018 | 4213 | 0.270 |
Why?
|
| Cardiac Output | 6 | 2004 | 156 | 0.260 |
Why?
|
| Male | 32 | 2017 | 40965 | 0.250 |
Why?
|
| Point-of-Care Systems | 2 | 1996 | 141 | 0.250 |
Why?
|
| Double-Blind Method | 10 | 2017 | 1823 | 0.250 |
Why?
|
| Radial Artery | 1 | 2004 | 33 | 0.250 |
Why?
|
| Emergencies | 2 | 1995 | 113 | 0.240 |
Why?
|
| Heart Diseases | 1 | 2007 | 290 | 0.240 |
Why?
|
| Muscle Relaxants, Central | 1 | 2003 | 10 | 0.240 |
Why?
|
| Conscious Sedation | 3 | 2004 | 64 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 746 | 0.220 |
Why?
|
| Blood Pressure | 5 | 2017 | 1143 | 0.220 |
Why?
|
| Anesthesia, Endotracheal | 1 | 2022 | 6 | 0.220 |
Why?
|
| Analgesia, Epidural | 1 | 2002 | 38 | 0.210 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2022 | 62 | 0.210 |
Why?
|
| Publishing | 1 | 2003 | 90 | 0.210 |
Why?
|
| Patient Positioning | 2 | 2014 | 63 | 0.210 |
Why?
|
| Ventricular Function, Left | 1 | 2006 | 592 | 0.200 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2001 | 31 | 0.200 |
Why?
|
| Antiemetics | 2 | 2014 | 98 | 0.200 |
Why?
|
| Vital Capacity | 1 | 2001 | 64 | 0.200 |
Why?
|
| Dexamethasone | 2 | 2014 | 326 | 0.200 |
Why?
|
| Delirium | 1 | 2001 | 66 | 0.190 |
Why?
|
| Sepsis | 1 | 2004 | 306 | 0.190 |
Why?
|
| Patient Handoff | 1 | 2022 | 93 | 0.190 |
Why?
|
| Oxygen | 6 | 2010 | 726 | 0.190 |
Why?
|
| Clinical Trials as Topic | 3 | 2016 | 1169 | 0.190 |
Why?
|
| Methadone | 2 | 2017 | 36 | 0.190 |
Why?
|
| Respiration, Artificial | 5 | 2014 | 334 | 0.190 |
Why?
|
| Anxiety | 2 | 2001 | 287 | 0.190 |
Why?
|
| Adult | 28 | 2017 | 25648 | 0.180 |
Why?
|
| Androstanols | 3 | 2004 | 10 | 0.170 |
Why?
|
| Pancuronium | 3 | 2004 | 9 | 0.170 |
Why?
|
| Blood Chemical Analysis | 2 | 1996 | 42 | 0.170 |
Why?
|
| Spinal Fusion | 2 | 2017 | 85 | 0.170 |
Why?
|
| Pain | 1 | 2001 | 391 | 0.170 |
Why?
|
| Analgesia | 2 | 2001 | 57 | 0.160 |
Why?
|
| Clinical Competence | 3 | 2001 | 751 | 0.160 |
Why?
|
| Safety Management | 1 | 2018 | 56 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2001 | 380 | 0.160 |
Why?
|
| Length of Stay | 6 | 2015 | 702 | 0.160 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 103 | 0.150 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2017 | 6 | 0.150 |
Why?
|
| Perinatal Care | 1 | 2017 | 18 | 0.150 |
Why?
|
| Thermodilution | 3 | 2004 | 21 | 0.150 |
Why?
|
| Opiate Substitution Treatment | 1 | 2017 | 30 | 0.150 |
Why?
|
| Postoperative Nausea and Vomiting | 3 | 2014 | 17 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 429 | 0.150 |
Why?
|
| Documentation | 1 | 2017 | 98 | 0.140 |
Why?
|
| Parenting | 1 | 2017 | 67 | 0.140 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 455 | 0.140 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2004 | 60 | 0.140 |
Why?
|
| Patient Safety | 1 | 2018 | 212 | 0.140 |
Why?
|
| Family Health | 2 | 2005 | 162 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 336 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 143 | 0.130 |
Why?
|
| Myography | 2 | 2011 | 4 | 0.130 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 399 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 161 | 0.120 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2014 | 34 | 0.120 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2014 | 135 | 0.120 |
Why?
|
| Conflict of Interest | 1 | 2014 | 67 | 0.120 |
Why?
|
| Catheterization, Central Venous | 3 | 2000 | 116 | 0.120 |
Why?
|
| Informed Consent | 1 | 2016 | 266 | 0.120 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 307 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 873 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 239 | 0.120 |
Why?
|
| Status Asthmaticus | 1 | 2013 | 9 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2017 | 7993 | 0.110 |
Why?
|
| Paralysis | 3 | 2005 | 23 | 0.110 |
Why?
|
| Aged, 80 and over | 9 | 2017 | 6509 | 0.110 |
Why?
|
| Myocardial Infarction | 3 | 2009 | 376 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 685 | 0.110 |
Why?
|
| Incidence | 2 | 2015 | 1577 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 379 | 0.100 |
Why?
|
| Intubation, Intratracheal | 4 | 2005 | 144 | 0.100 |
Why?
|
| Equipment Design | 4 | 2000 | 406 | 0.100 |
Why?
|
| Models, Organizational | 2 | 2015 | 46 | 0.100 |
Why?
|
| Data Collection | 1 | 2012 | 372 | 0.100 |
Why?
|
| Adolescent | 5 | 2017 | 8981 | 0.100 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2011 | 50 | 0.090 |
Why?
|
| Fatigue | 1 | 2011 | 174 | 0.090 |
Why?
|
| Forecasting | 3 | 2015 | 304 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2013 | 265 | 0.090 |
Why?
|
| Young Adult | 3 | 2017 | 5976 | 0.090 |
Why?
|
| United States | 5 | 2016 | 6672 | 0.090 |
Why?
|
| Arthroscopy | 1 | 2010 | 94 | 0.090 |
Why?
|
| Telemedicine | 1 | 2012 | 169 | 0.090 |
Why?
|
| Anesthesia, Intravenous | 1 | 2009 | 35 | 0.090 |
Why?
|
| Contraindications | 1 | 2009 | 72 | 0.090 |
Why?
|
| Shoulder Joint | 1 | 2010 | 90 | 0.090 |
Why?
|
| Intraoperative Period | 2 | 2022 | 90 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 1036 | 0.080 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2008 | 26 | 0.080 |
Why?
|
| Electroencephalography | 1 | 2012 | 709 | 0.080 |
Why?
|
| Laminectomy | 1 | 2008 | 27 | 0.080 |
Why?
|
| Butyrylcholinesterase | 1 | 1988 | 10 | 0.080 |
Why?
|
| Cholinesterases | 1 | 1988 | 17 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 865 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2008 | 88 | 0.080 |
Why?
|
| Computers | 1 | 1987 | 112 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2013 | 2261 | 0.080 |
Why?
|
| Heart Function Tests | 1 | 2007 | 30 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1988 | 124 | 0.070 |
Why?
|
| Expert Testimony | 1 | 2007 | 46 | 0.070 |
Why?
|
| Nerve Block | 2 | 2010 | 51 | 0.070 |
Why?
|
| Axillary Artery | 1 | 2006 | 10 | 0.070 |
Why?
|
| Systole | 1 | 2007 | 129 | 0.070 |
Why?
|
| Diastole | 1 | 2007 | 144 | 0.070 |
Why?
|
| Cardiac Catheterization | 1 | 1988 | 291 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2006 | 36 | 0.070 |
Why?
|
| Hemoglobins | 2 | 1998 | 179 | 0.070 |
Why?
|
| Central Venous Pressure | 1 | 2006 | 26 | 0.070 |
Why?
|
| Plasmapheresis | 1 | 1986 | 26 | 0.070 |
Why?
|
| Risk Factors | 3 | 2012 | 5417 | 0.070 |
Why?
|
| Milk, Human | 1 | 2006 | 43 | 0.070 |
Why?
|
| Lactation | 1 | 2006 | 53 | 0.070 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2006 | 16 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 1673 | 0.070 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2006 | 36 | 0.070 |
Why?
|
| Troponin I | 1 | 2006 | 27 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 56 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 187 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 244 | 0.070 |
Why?
|
| Consumer Behavior | 1 | 2005 | 29 | 0.070 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 57 | 0.070 |
Why?
|
| Heparin | 1 | 1986 | 175 | 0.070 |
Why?
|
| Anesthesia, Inhalation | 1 | 2005 | 36 | 0.070 |
Why?
|
| Heart | 1 | 1988 | 539 | 0.070 |
Why?
|
| Prognosis | 1 | 2013 | 3679 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 1986 | 183 | 0.060 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2004 | 28 | 0.060 |
Why?
|
| Carotid Artery, Common | 1 | 2004 | 29 | 0.060 |
Why?
|
| Arteries | 3 | 2000 | 176 | 0.060 |
Why?
|
| Information Management | 1 | 2004 | 7 | 0.060 |
Why?
|
| Extracorporeal Circulation | 1 | 2004 | 26 | 0.060 |
Why?
|
| Health Priorities | 1 | 2004 | 23 | 0.060 |
Why?
|
| Propofol | 2 | 2006 | 89 | 0.060 |
Why?
|
| Nurses | 1 | 2004 | 40 | 0.060 |
Why?
|
| Family | 1 | 2005 | 311 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2004 | 97 | 0.060 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2004 | 108 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 165 | 0.060 |
Why?
|
| Nervous System | 1 | 2003 | 86 | 0.050 |
Why?
|
| Embolism | 1 | 1982 | 31 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2004 | 128 | 0.050 |
Why?
|
| Patient Care Team | 2 | 2015 | 280 | 0.050 |
Why?
|
| Breast Feeding | 2 | 2017 | 91 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 3 | 1998 | 274 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 839 | 0.050 |
Why?
|
| Linear Models | 1 | 2003 | 421 | 0.050 |
Why?
|
| Hypothermia | 1 | 2001 | 26 | 0.050 |
Why?
|
| Research Design | 1 | 2005 | 594 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2004 | 456 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2001 | 65 | 0.050 |
Why?
|
| Hand | 1 | 1982 | 130 | 0.050 |
Why?
|
| Electric Countershock | 1 | 2001 | 47 | 0.050 |
Why?
|
| Positive-Pressure Respiration | 3 | 1992 | 41 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2001 | 65 | 0.050 |
Why?
|
| Catheterization | 1 | 1982 | 232 | 0.050 |
Why?
|
| Echocardiography | 1 | 2006 | 911 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 636 | 0.050 |
Why?
|
| Ischemia | 1 | 1982 | 243 | 0.050 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2000 | 10 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2000 | 43 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 449 | 0.050 |
Why?
|
| Heart Rate | 2 | 2014 | 492 | 0.040 |
Why?
|
| Pain Measurement | 3 | 2009 | 321 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 69 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2001 | 271 | 0.040 |
Why?
|
| Time Factors | 2 | 2010 | 5210 | 0.040 |
Why?
|
| Compliance | 1 | 2018 | 23 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2001 | 156 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2011 | 303 | 0.040 |
Why?
|
| Biosensing Techniques | 2 | 1996 | 68 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1996 | 493 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 1998 | 81 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 1998 | 110 | 0.040 |
Why?
|
| Credentialing | 1 | 1997 | 13 | 0.040 |
Why?
|
| Homeostasis | 1 | 2000 | 409 | 0.040 |
Why?
|
| Buprenorphine | 1 | 2017 | 33 | 0.040 |
Why?
|
| Carbon Dioxide | 2 | 2014 | 188 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 912 | 0.040 |
Why?
|
| Hematocrit | 1 | 1996 | 68 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 1996 | 35 | 0.030 |
Why?
|
| Atracurium | 1 | 1995 | 5 | 0.030 |
Why?
|
| Vecuronium Bromide | 1 | 1995 | 3 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 2015 | 39 | 0.030 |
Why?
|
| Educational Measurement | 1 | 1997 | 225 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 1995 | 42 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1996 | 153 | 0.030 |
Why?
|
| Professional-Family Relations | 2 | 2005 | 48 | 0.030 |
Why?
|
| Acid-Base Imbalance | 1 | 1995 | 4 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 894 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 35 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2014 | 25 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1995 | 55 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 130 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2015 | 2767 | 0.030 |
Why?
|
| Health Care Reform | 1 | 1995 | 90 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 60 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1994 | 27 | 0.030 |
Why?
|
| Shoulder | 1 | 2014 | 42 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2005 | 297 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 53 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 174 | 0.030 |
Why?
|
| Survival Rate | 1 | 1998 | 1863 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 144 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2501 | 0.030 |
Why?
|
| Logistic Models | 2 | 2010 | 1186 | 0.030 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 1993 | 23 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 1993 | 44 | 0.030 |
Why?
|
| Kinetocardiography | 1 | 2013 | 1 | 0.030 |
Why?
|
| Neuromuscular Monitoring | 1 | 2013 | 3 | 0.030 |
Why?
|
| Physician's Role | 1 | 2015 | 179 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1994 | 118 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2014 | 176 | 0.030 |
Why?
|
| Decision Making | 1 | 1998 | 642 | 0.030 |
Why?
|
| Comorbidity | 1 | 2015 | 943 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 12 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 2379 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2015 | 428 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1379 | 0.020 |
Why?
|
| Pregnancy | 2 | 2017 | 2894 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1851 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 1991 | 0.020 |
Why?
|
| Supine Position | 1 | 2010 | 30 | 0.020 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2011 | 74 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2005 | 347 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 582 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2705 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 364 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 752 | 0.020 |
Why?
|
| Neuromuscular Junction | 2 | 2002 | 80 | 0.020 |
Why?
|
| Acceleration | 1 | 2008 | 20 | 0.020 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1988 | 3 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2011 | 397 | 0.020 |
Why?
|
| Conjunctiva | 1 | 1988 | 19 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2011 | 300 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1988 | 370 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2008 | 221 | 0.020 |
Why?
|
| Suction | 1 | 1987 | 35 | 0.020 |
Why?
|
| Respiration | 1 | 2008 | 262 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 1987 | 44 | 0.020 |
Why?
|
| Tracheostomy | 1 | 1987 | 42 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 1986 | 44 | 0.020 |
Why?
|
| Midazolam | 1 | 2006 | 48 | 0.020 |
Why?
|
| Radiography | 2 | 1993 | 813 | 0.020 |
Why?
|
| Platelet Count | 1 | 1986 | 92 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 197 | 0.020 |
Why?
|
| Hemodilution | 1 | 2006 | 13 | 0.020 |
Why?
|
| Nursing Care | 1 | 2005 | 3 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2005 | 48 | 0.020 |
Why?
|
| Neostigmine | 1 | 2005 | 6 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2005 | 45 | 0.020 |
Why?
|
| Caregivers | 1 | 2005 | 151 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 1718 | 0.010 |
Why?
|
| Perfusion | 1 | 2004 | 203 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2006 | 349 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 2003 | 24 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 319 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1801 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2002 | 278 | 0.010 |
Why?
|
| Arm | 1 | 1982 | 91 | 0.010 |
Why?
|
| Communication | 1 | 2005 | 441 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2006 | 8489 | 0.010 |
Why?
|
| Punctures | 1 | 2000 | 29 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2001 | 401 | 0.010 |
Why?
|
| Ethchlorvynol | 1 | 1980 | 2 | 0.010 |
Why?
|
| Swine | 1 | 2001 | 555 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 177 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 3640 | 0.010 |
Why?
|
| Body Temperature | 1 | 1998 | 124 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1998 | 197 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1982 | 1565 | 0.010 |
Why?
|
| Child | 1 | 1988 | 6927 | 0.010 |
Why?
|
| Ulnar Nerve | 1 | 1995 | 6 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1995 | 102 | 0.010 |
Why?
|
| Animals | 2 | 2001 | 26582 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1156 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1994 | 50 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 429 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1994 | 35 | 0.010 |
Why?
|
| Mice | 1 | 1988 | 11352 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 222 | 0.010 |
Why?
|
| Intervertebral Disc | 1 | 1993 | 16 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 1993 | 27 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1993 | 54 | 0.010 |
Why?
|
| Algorithms | 1 | 2001 | 1830 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 118 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 1993 | 79 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1961 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1998 | 827 | 0.010 |
Why?
|
| Reoperation | 1 | 1993 | 597 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1980 | 244 | 0.000 |
Why?
|